Leptin

Lancet

Volumn 351, Issue 9104, 1998, Pages 737-742

  Auwerx, Johan ^a   Staels, Bart ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADIPOCYTE; BODY WEIGHT; ENERGY EXPENDITURE; HUMAN; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032492453     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06348-4     Document Type: Review

References (96)

1. 1 Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377-89.
2. 2 Auwerx J, Martin G, Guerre-Millo M, Staels B. Transcription, adipocyte differentiation, and obesity. J Mol Med 1996; 74: 347-52.
3. 3 Caro J, Sinha MK, Kolaczynski LW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-62.
4. 4 Campfield LA, Smith FJ, Burn P. The ob protein (leptin) pathway -a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28: 619-32.
5. 5 Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci USA 1997; 94: 4242-45.
6. 6 Tartaglia L. The leptin receptor. J Biol Chem 1997; 272: 6093-96.
7. 7 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
8. 8 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein; evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-49.
9. 9 Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-46.
10. 10 Pelleymounter MA, Cullen MJ, Baker MB, et al. Effect of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-43.
11. 11 Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-32.
12. 12 Weigle DS, Bukowski TR, Foster DC, et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96: 2065-70.
13. 13 Chen G, Koyama K, Yuan X, et al. Dissapearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 1996; 93: 14795-99.
14. 14 Muzzin P, Eisensmith RC, Copeland KC, Woo SLC. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 1996; 93: 14804-08.
15. 15 Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389: 379-77.
16. 16 Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
17. 17 Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-35.
18. 18 Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491-95.
19. 19 Ihle J. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331-34.
20. 20 Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997; 11: 393-399.
21. 21 Baumann H, Morella KK, White DW, et al. The full length leptin receptor has signalling capabilities of interleukin 6-type receptors. Proc Natl Acad Sci USA 1996; 93: 8374-78.
22. 22 Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. defective STAT signalling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93: 6231-35.
23. 23 Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95-97.
24. 24 Darnell JE. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc Natl Acad Sci USA 1996; 93: 6221-24.
25. 25 Chua SC, Chung WK, Wu-Peng S, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994-96.
26. 26 Philips MS, Liu Q, Hammond HA, et al. Leptin receptor missense mutations in the fatty Zucker rat. Nat Genet 1996; 13: 18-19.
27. 27 Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 1996; 222: 19-26.
28. 28 Takaya K, Ogawa Y, Isse N, et al. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 1996; 225: 75-83.
29. 29 Takaya K, Ogawa Y, Hiraoka J, et al. Nonsense mutation of the leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 1996; 14: 130-31.
30. 30 Schwartz MW, Seeley RJ, Campfield LA, Burn P. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-06.
31. 31 Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-11.
32. 32 Golden PL, Maccagnan TJ, Pardridge WM. Human blood-barrier leptin receptor; binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997; 99: 14-18.
33. 33 Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274: 1704-07.
34. 34 Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415-18.
35. 35 Fan W, Boston BA, Kesterton RA, Hruby VJ, Cone RD. Role of melanocotinergic neurons in feeding and the agouti obesity syndrome. Nature 1996; 385: 165-68.
36. 36 Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melancocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-41.
37. 37 Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996; 379: 69-72.
38. 38 Arase K, York DA, Shimizu H, Shargill N, Bray GA. Effect of corticotropin-releasing factor on food intake and brown tissue thermogenesis in rats. Am J Physiol 1988; 255: E255-E259.
39. 39 Spina M, Merlo-Pich E, Chan RKW, et al. Appetite-suppressing effects of urocortin a CRF-related neuropeptide. Science 1996; 273: 1561-1564.
40. 40 Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995; 373: 427-32.
41. 41 Qu D, Ludwig DS, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996; 380: 243-47.
42. 42 Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-88.
43. 43 Bai Y, Zhang S, Kim KS, Lee JK, Kim KH. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 1996; 271: 13939-42.
44. 44 Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585-93.
45. 45 Gainsford T, Wilson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996; 93: 14564-68.
46. 46 Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-41.
47. 47 Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-88.
48. 48 Maffei M, et al. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 1996; 45: 679-682.
49. 49 Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human ob gene. Diabetes 1996; 45: 691-94.
50. 50 Stirling B, Cox NJ, Bell GI, Hanis CL, Spielman RS, Concannon P. Identification of microsatellite markers near the human ob gene and linkage studies in NIDDM-affected sib pairs. Diabetes 1995; 44: 999-1001.
51. 51 Clement K, Garner C, Hager J, et al. Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996; 45: 687-690.
52. 52 Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
53. 53 Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-95.
54. 54 Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1155-1161.
55. 55 Lönnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995; 1: 950-53.
56. 56 Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995; 1: 954-56.
57. 57 Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 1996; 98: 251-55.
58. 58 Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-61.
59. 59 Schwartz M, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2: 589-93.
60. 60 Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996; 12: 318-20.
61. 61 Chehab FF, Mounzih K, Lu R, Lin ME. Early onset of reproductive function in normal female mice treated with leptin. Science 1997; 275: 88-90.
62. 62 Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997; 138: 855-88.
63. 63 Barash IA, Cheung CC, Weigle DS, et al. Leptin is a signal to the reproductive system. Endocrinology 1996; 137: 3144-47.
64. 64 Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-52.
65. 65 Frederich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995; 96: 1658-63.
66. 66 Masuzaki H, Ogawa Y, Sagawa N, et al. Non-adipose tissue production of leptin; leptin as a novel placenta-derived hormone in humans. Nat Med 1997; 3: 1029-33.
67. 67 Ravussin E, Pratley RE, Maffei M, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 1997; 3: 238-40.
68. 68 Cumin F, Baum HP. Leptin is cleared from the circulation primarily by the kidney. Int J Obes 1996; 20: 1120-26.
69. 69 Merabet E, Dagogo-Jack S, Coyne DW, et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82: 847-50.
70. 70 Sharma K, Considine RV, Michael B, et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51: 1980-85.
71. 71 Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994; 79: 1147-56.
72. 72 Zhang B, Graziano MP, Doebber TW, et al. Down-regulation of the expression of the obese gene by antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 1996; 271: 9455-59.
73. 73 De Vos P, Lefebvre AM, Miller SG, et al. Thiazolidinediones repress ob gene expresson via activation of PPARγ. J Clin Invest 1996; 98: 1004-09.
74. 74 Kallen CB, Lazar MA. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1996; 93: 5793-96.
75. 75 Nolan JJ, Olefsky JM, Nyce MR, Considine RV, Caro JF. Effect of troglitazone on leptin production: studies in vitro and in human subjects. Diabetes 1996; 45: 1276-78.
76. 76 Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: a role for leptin in the anorexia of infection. J Clin Invest 1996; 97: 2152-57.
77. 77 De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995; 270: 15958-61.
78. 78 Miller SG, De Vos P, Guerre-Millo M, et al. The adipocyte specific transcription factor, C/EBPa modulates human ob gene expression. Proc Natl Acad Sci USA 1996; 93: 5507-11.
79. 79 He Y, Chen H, Quon MJ, Reitman M. The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem 1995; 270: 28887-91.
80. 80 Hollenberg AN, Susulic VS, Madura JP, et al. Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter. J Biol Chem 1997; 272: 5283-90.
81. 81 Zhang B, Berger J, Hu E, et al. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the adipogenic effect of tumor necrosis factor-α. Mol Endocrinol 1996; 10: 1457-66.
82. 82 Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15: 273-76.
83. 83 Saladin R, Staels B, Auwerx J, Briggs M. Regulation of ob gene expression in rodents and humans. Horm Metab Res 1996; 28: 638-41.
84. 84 Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake and insulin administration. Nature 1995; 377: 527-29.
85. 85 MacDougold OA, Hwang CS, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1995; 92: 9034-37.
86. 86 Trayhurn P, Thomas MEA, Duncan JS, Rayner VD. Effect of fasting and refeeding on ob gene expression in white adipose tissue of lean and (ob/ob) mice. FEBS Lett 1995; 368: 488-90.
87. 87 Moinat M, Deng C, Muzzin P, et al. Modulation of obese gene expression in rat brown and white adipose tissues. FEBS Lett 1995; 373: 131-34.
88. 88 MacDougald O, Lane D. Transcriptional regulation of gene expression during adipocyte differentiation. Ann Rev Biochem 1995; 64: 345-73.
89. 89 Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in adipose cells: regulation by insulin. J Biol Chem 1996; 271: 2365-68.
90. 90 Kolaczynski JW, Considine RV, Ohannesian J, et al. Response of leptin to short term fasting and refeeding in humans. Diabetes 1996; 45: 1511-15.
91. 91 Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-23.
92. 92 Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996; 81: 4162-65.
93. 93 Wabitsch M, Jensen PB, Blum WF, et al. Insulin and cortisol promote leptin prodution in cultured human fat cells. Diabetes 1996; 45: 1435-38.
94. 94 Malmstrom R, Taskinen MR, Karonen SL, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-96.
95. 95 Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997; 82: 654-57.
96. 96 Dallongeville J, Le Fur C, Lebel P, et al. The increase in serum leptin levels after food intake is correlated with insulin levels in normal subjects. Diabetes 1997; (submitted).